Core needle biopsy for the diagnosis of breast tumor
10.3760/cma.j.issn.1007-631X.2009.08.009
- VernacularTitle:核心针活检在乳腺病变诊断和乳腺癌新辅助化疗中的应用价值
- Author:
Bailin ZHANG
;
Xiaozhou XU
;
Xun YANG
;
Shan ZHENG
;
Zhongzhao WANG
;
Ning LU
;
Xiang WANG
;
Baoning ZHANG
- Publication Type:Journal Article
- Keywords:
Breast neoplasms;
Biopsy;
Immunohistochemistry
- From:
Chinese Journal of General Surgery
2009;24(8):631-633
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the accuracy of core needle biopsy (CNB) in diagnosing breast masses and its coherence with immunohistochemical (IHC) examination results of estrogen receptor (ER), progesterone receptor (PR) and Her2 protein between pre-and post-chemotherapy in invasive breast cancer. Methods The results of 516 CNB cases from June, 2005 to April, 2008 were analyzed retrospectively. The pathological examination was performed by two pathologists independently. Results 484 cases of malignant tumor, carcinoma in situ and phyllodes tumor were found in this group with the sensitivity of 96.7%. Sixteen cases of false negative (3. 3% ) were demonstrated by surgical biopsy. The accurate rate of CNB was not influenced by the maximum diameter of masses ( P = O. 423 ). The agreement rate of IHC results of ER, PgR and Her2 between pre- and post-chemotherapy were 90. 3%, 76. 8% and 82.5%, respectively. Conclusion CNB is a useful diagnostic method with a satisfactory accuracy in any size of breast masses. Given the histological heterogeneity of invasive breast cancer and the influence of ehemotherapy, the coherence of prechemotherapy IHC for ER, PgR and Her2 is not optimal with that of post-chemotherapy.
